Home › Funds › Blue Owl Capital Holdings LP › CABA
Blue Owl Capital Holdings LP position in CABA
CABALETTA BIO INC · Health Care
Blue Owl Capital Holdings LP reported holding 714,710 shares of CABA (CABALETTA BIO INC) in its Q2 2026 13F filing — a position valued at US$2.2M, representing 0.36% of its reported portfolio and ranking #28 among its reported holdings. Blue Owl Capital Holdings LP has disclosed CABA holdings in 2 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Blue Owl Capital Holdings LP's CABA position evolved
Blue Owl Capital Holdings LP first disclosed a stake in CABA in Q2 2025 at 1,125,000 shares (US$1.7M). The position peaked in Q2 2026 at 714,710 shares, worth US$2.2M. Across 2 filings, Blue Owl Capital Holdings LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 714,710 shares valued at US$2.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 1.12M | $1.71M | New |
| Q2 2026 | 714.71K | $2.22M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CABA and 13F data
CABA (CABALETTA BIO INC) is a Health Care company. 37 other funds we track also report a position in CABA — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$53.6M), Cormorant Asset Management, LP (US$15.6M), Opaleye Management Inc. (US$12.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CABA
- Bain Capital Life Sciences Investors, LLC 17.24M sh · $53.62M · Q2 2026
- Cormorant Asset Management, LP 5.00M sh · $15.55M · Q2 2026
- Opaleye Management Inc. 3.86M sh · $12.02M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 1.28M sh · $3.48M · Q2 2026
- Stonepine Capital Management, LLC 917.10K sh · $2.85M · Q2 2026
More on Blue Owl Capital Holdings LP
FAQ
How long has Blue Owl Capital Holdings LP held CABA?
Blue Owl Capital Holdings LP has disclosed CABA holdings in 2 of the last 5 reported quarters, going back to Q2 2025.
What is Blue Owl Capital Holdings LP's current position in CABA?
As of Q2 2026, Blue Owl Capital Holdings LP holds 714.71K shares of CABA (CABALETTA BIO INC), valued at $2.22M, representing 0.36% of its reported portfolio and ranking #28.
Has Blue Owl Capital Holdings LP been buying or selling CABA?
In the latest 13F filing (Q2 2026), Blue Owl Capital Holdings LP newly opened its position in CABA. The position peaked in Q2 2026 at 714.71K shares.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Cormorant Asset Management, LP, Opaleye Management Inc., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.